Research
Hormonal
Orlistat and Liraglutide are currently available medication options for long-term obesity treatment in Germany.
Clinicians can prescribe Orlistat or Liraglutide for patients needing long-term obesity management.
StrongSupportsmedium confidence
Als medikamentöse Therapieoption stehen aktuell in Deutschland der Lipaseinhibitor Orlistat sowie der GLP-1 Rezeptor-Agonist (GLP-1RA) Liraglutid zur medikamentösen Langzeittherapie der Adipositas zur Verfügung.
Why this rating
The claim is based on current clinical practice guidelines.
Source
Medikamentöse Adipositastherapie – Chancen und Perspektiven
Anne Lautenbach et al. · Adipositas - Ursachen Folgeerkrankungen Therapie · 2021
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →